Filter Results:
(617)
Show Results For
- All HBS Web
(617)
- People (2)
- News (55)
- Research (446)
- Events (2)
- Multimedia (8)
- Faculty Publications (391)
Show Results For
- All HBS Web
(617)
- People (2)
- News (55)
- Research (446)
- Events (2)
- Multimedia (8)
- Faculty Publications (391)
- January 2014 (Revised June 2015)
- Case
Amgen Inc.: Pursuing Innovation and Imitation? (A)
By: Ian W. Mackenzie
Set in 2009, the (A) case explores whether Amgen, a leading innovator of biotech-based drugs, should enter the emerging business of biosimilars (BS), which are essentially 'me-too' products. There appear to be sound reasons to explore this related diversification:... View Details
Mackenzie, Ian W. "Amgen Inc.: Pursuing Innovation and Imitation? (A)." Harvard Business School Case 714-424, January 2014. (Revised June 2015.)
- April 2023
- Case
Drive Capital: A New Road for Venture
By: Paul A. Gompers and Alicia Dadlani
Founded by two former Sequoia Capital partners, Columbus-Ohio-based Drive Capital’s mission was to build a world-class venture capital firm in the middle of the U.S., an area historically overlooked by VCs. Drive faced early challenges of attracting investors, sourcing... View Details
Keywords: Venture Capital; Business Startups; Entrepreneurship; Investment; Business Strategy; Biotechnology Industry; Biotechnology Industry; United States; Ohio
Gompers, Paul A., and Alicia Dadlani. "Drive Capital: A New Road for Venture." Harvard Business School Case 823-056, April 2023.
- Web
Industry Information - Alumni
recruitment and job seeking opportunities for professionals in the biotechnology and pharmaceutical industries. + – Hospitality Hospitality - General SmartBriefs – Travel Newsletter digest of hospitality industry headlines produced in... View Details
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation ＆ Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- January 2017
- Case
Danaher Corporation, 2007–2017
By: John R. Wells and Gabriel Ellsworth
On July 2, 2016, Danaher Corporation completed the spinoff of Fortive Corporation. The previous day, Danaher’s stock price had reached an all-time high. In 2015, Danaher had decided to split off its test and measurement, fuel and fleet management, and automation... View Details
Keywords: Danaher; Fortive; Larry Culp; Beckman Coulter; Pall; Life Sciences; Diagnostics; Environmental Operations; Water Management; Dental; Testing; Measurement; Fuel; Fleet Management; Automation; Toolmaking; Tools; Disease Management; Continuous Improvement; Toyota Production System; Divestiture; Spinoffs; Spin-off; Networks; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Divisions; Business Subsidiaries; Business Units; Business Growth and Maturation; Business Model; For-Profit Firms; Joint Ventures; Restructuring; Engineering; Chemicals; Construction; Machinery and Machining; Profit; Revenue; Globalized Firms and Management; Multinational Firms and Management; Health; Health Care and Treatment; Health Disorders; Medical Specialties; Business History; Job Cuts and Outsourcing; Business or Company Management; Growth and Development Strategy; Management Analysis, Tools, and Techniques; Management Practices and Processes; Management Succession; Management Systems; Resource Allocation; Market Entry and Exit; Measurement and Metrics; Logistics; Business Processes; Organizational Change and Adaptation; Public Ownership; Problems and Challenges; Science; Genetics; Natural Environment; Wastes and Waste Processing; Science-Based Business; Opportunities; Strategy; Adaptation; Business Strategy; Competition; Competitive Strategy; Competitive Advantage; Consolidation; Corporate Strategy; Diversification; Expansion; Technology; Software; Technology Networks; Technology Platform; Value; Valuation; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States; District of Columbia
Wells, John R., and Gabriel Ellsworth. "Danaher Corporation, 2007–2017." Harvard Business School Case 717-464, January 2017.
- 01 Aug 1998
- News
High Honors
education." McDermott hasn't slowed down in retirement, concentrating his energy and vision on an array of community-related projects. Among them is the Texas Research and Technology Foundation, which he established in 1984 to develop San Antonio's Texas Research Park,... View Details
- January 2021 (Revised June 2023)
- Case
Biobot Analytics
In 2017, Newsha Ghaeli and Mariana Matus were deciding whether to leave their labs at the Massachusetts Institute of Technology, put other job opportunities aside, and dive full-time into founding a wastewater analysis start-up, Biobot. Ghaeli, an architect, and Matus,... View Details
Keywords: Entrepreneurship; Information Technology; City; Analytics and Data Science; Personal Development and Career; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States; Kuwait; Korean Peninsula
Kluender, Raymond, Joshua Krieger, and Mitchell Weiss. "Biobot Analytics." Harvard Business School Case 821-045, January 2021. (Revised June 2023.)
- September 2013 (Revised August 2015)
- Background Note
Leadership and Teaming
By: Ethan Bernstein
Small differences in the leadership of teams can have large consequences for the success of their efforts. Many initiatives fail not because of a fatal error in judgment or insufficient ideas, knowledge, motivation, or capabilities to deliver a solution. They fail... View Details
Keywords: Teams; Teaming; Leadership And Managing People; Leadership; Team Effectiveness; Team Performance; Team Design; Team Leadership; Teamwork; Team Process; Team Function; Team Launch; 60/30/10 Rule; Team Boundary; Distribution Of Leadership Authority; Self-Managed Teams; Virtual Teams; Unbounded Teams; Acts Of Leadership; Execution Teams; Decision Making Teams; Creativity Teams; Team Size; Task Design; Team Timeline; Team Roles; Team Representation; Diversity; Team Familiarity; Collective Intelligence; Team Stages Of Development; Team Coaching; Performance Pressure; X-Teams; Team Focus; Interaction; Management Teams; Managerial Roles; Management Systems; Management Style; Management Skills; Management Practices and Processes; Organizational Design; Organizational Structure; Performance Effectiveness; Performance Efficiency; Performance Productivity; Groups and Teams; Networks; Social Psychology; Behavior; Conflict and Resolution; Creativity; Social and Collaborative Networks; Satisfaction; Prejudice and Bias; Power and Influence; Personal Characteristics; Familiarity; Cognition and Thinking; Attitudes; Projects; Organizational Culture; Organizational Change and Adaptation; Leadership Development; Leadership Style; Leading Change; Knowledge Use and Leverage; Knowledge Sharing; Collaborative Innovation and Invention; Innovation and Management; Innovation Leadership; Design; Interpersonal Communication; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Asia; North and Central America; South America; Atlantic Ocean; Central Asia; Europe; Latin America; Middle East; Oceania; West Indies
Bernstein, Ethan. "Leadership and Teaming." Harvard Business School Background Note 414-033, September 2013. (Revised August 2015.)
- Profile
Arjun Goyal
the possibilities, Arjun sought “a better understanding of how to go from lab work to medical product” by taking an internship (after fulfilling his medical residency in Sydney, Australia) with Celtic Therapeutics in New York City. One of the first View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
heralding the start of National Biotechnology Month, as January 2000 had been designated by the U.S. Senate. For biotech, in fact, the party had begun months earlier, when hundreds of millions of dollars had poured into promising... View Details
- Profile
Henry McCance
Twelve years ago, when Henry McCance (MBA 1966) and his wife initially faced her diagnosis of Alzheimer’s disease, the couple consulted some of the world’s top physicians specializing in its treatment. McCance was shocked by their advice. “They said, ‘Try three Advil a... View Details
Gordon M. Binder
Binder led Amgen to become the first commercially successful and largest independent biotechnology company in the world employing over 6,000 individuals and generating in excess of $3 billion in revenue. In 1999, Binder was named Chairman... View Details
Keywords: Healthcare
- 13 Aug 2019
- Blog Post
What is the MS/MBA Biotechnology: Life Sciences Program?
Cara Sterling, the Director of the HBS Health Care Initiative, and get your top questions about the new program answered. View Video Clear Admit Podcast : Insights into Harvard’s New Joint Degree, MS/MBA Biotechnology – Life Sciences... View Details
- 13 Nov 2006
- Research & Ideas
Science Business: What Happened to Biotech?
very broadest terms, everyone expected biotech to "work" just like all other high-technology industries, and thus we deployed a lot of the same thinking, models, financial arrangements, and strategies that worked elsewhere, but just didn't fit here. Q: The... View Details
- 05 Feb 2019
Healthcare Webinar
This webinar will feature a panel of current students who have worked in the healthcare, biotechnology or pharmaceutical industry. View Details
- 18 Oct 2022
MS/MBA Information Session and Q&A
Join HBS MS/MBA students and alumni to learn more about the MS/MBA Engineering Sciences and MS/MBA Biotechnology programs at Harvard. You've got questions - we've got the answers! View Details
- 15 Nov 2024
MS/MBA "Ask Me Anything"
Hear directly from current MS/MBA Engineering Sciences and MS/MBA Biotechnology alumni and students regarding their experience. They will be prepared to answer all of your questions, so come ready with questions! View Details
- 13 Dec 2024
MS/MBA "Ask Me Anything"
Hear directly from current MS/MBA Engineering Sciences and MS/MBA Biotechnology alumni and students regarding their experience. They will be prepared to answer all of your questions, so come ready with questions! View Details
- 30 Jul 2024
MS/MBA Virtual Chat with Alumni
Hear directly from current MS/MBA Engineering Sciences and MS/MBA Biotechnology alumni and students regarding their experience. Students and alumni will share their backgrounds and paths to the HBS MS/MBA, their experience in the joint... View Details
Robert P. Luciano
Luciano generated top-level financial performance while streamlining Schering’s business operations. He divested Schering’s non-healthcare related business lines and was one of the first pharmaceutical executives to recognize the potential for biotechnology. His early... View Details
Keywords: Healthcare